Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.40 |
| ▸ | CNR1 | P21554 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 8/20 | 0.38 |
| ▸ | HTR2C | P28335 | 8/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 7/20 | 0.38 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17645169 | 0.93 | CNR2 (0.40) | CNR2CNR1HTR2AHTR2CSLC6A4 | |
| SCHEMBL17645148 | 0.86 | CNR1 (0.38) | CNR2CNR1HTR2AHTR2CSLC6A4 | |
| SCHEMBL17645147 | 0.81 | CNR1 (0.38) | CNR2CNR1HTR2AHTR2CSLC6A4 | |
| SCHEMBL17645261 | 0.79 | CNR2 (0.67) | CNR2CNR1 | |
| SCHEMBL17645339 | 0.78 | CNR2 (0.44) | CNR2CNR1HTR2AHTR2CSLC6A4 | |
| SCHEMBL17645275 | 0.75 | CNR1 (0.47) | CNR2CNR1 | |
| SCHEMBL17645274 | 0.69 | CNR1 (0.47) | CNR2CNR1 | |
| SCHEMBL16404223 | 0.65 | CNR2 (0.65) | CNR2CNR1SMN1; SMN2 | |
| SCHEMBL17645425 | 0.61 | CNR1 (0.60) | CNR2CNR1 | |
| SCHEMBL600669 | 0.58 | CA12 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10053444-B2 | Cannabinergic nitrate esters and related analogs | UNIVERSITY OF CONNECTICUT (US) | 2018-08-21 | — | — | US | disclosed |
| US-20170001980-A9 | Novel Cannabinergic Nitrate Esters and Related Analogs | UNIVERSITY OF CONNECTICUT | 2017-01-05 | — | — | US | disclosed |
| US-20160096822-A1 | Novel Cannabinergic Nitrate Esters and Related Analogs | MAKRIYANNIS ALEXANDROS (US) | 2016-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10053444-B2 | Cannabinergic nitrate esters and related analogs | CNR2, CNR1, NOS3 | CNR2 1/4885CNR1 2/4885LMNA 2197/4885 |
| US-20160096822-A1 | Novel Cannabinergic Nitrate Esters and Related Analogs | CNR2, CNR1, CHRNB4 | CNR2 1/4885CNR1 2/4885LMNA 2791/4885 |
| US-20170001980-A9 | Novel Cannabinergic Nitrate Esters and Related Analogs | CNR2, CNR1, CHRNB4 | CNR2 1/4885CNR1 2/4885LMNA 2791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.